4.0
Mar 10, 2024
Recommend
CEO approval
Business Outlook
Pros
Innovative pipelines both in-house and in-license, a lot of learning opportunities.
Cons
Overwhelming workload in oncology, talent retention/new hires can't keep the exponential growth of portfolio in oncology.